Crispin Hiley, UK Clinical Director for Lung Cancer at GenesisCare and Consultant Oncologist at the University College London Hospitals NHS Foundation Trust, shared a post on X by Journal of Clinical Oncology about their paper by Yang Zhang et al.:
“No role for mediastinal LN dissection in clinical stage T1N0M0 GGO-dominant invasive lung adeno, defined by consolidation-to-tumor ratio (CTR) ≤0.5 and maximum tumor diameter (including solid and GGO components) ≤3 cm. Zero positive hilar nodes in those that were resected!”
Quoting Journal of Clinical Oncology’s post:
“Phase III Study of Mediastinal Lymph Node Dissection for Ground Glass Opacity–Dominant Lung Adenocarcinoma.
Read the full article.”
Title: Phase III Study of Mediastinal Lymph Node Dissection for Ground Glass Opacity–Dominant Lung Adenocarcinoma
Authors: Yang Zhang, Bin Qian, Qingping Song, Junjie Ma, Hang Cao, Chaoqiang Deng, Shengping Wang, Ting Ye, Jiaqing Xiang, Yawei Zhang, Yihua Sun, Yueren Yan, Shanbo Zheng, Haoxuan Wu, Qingyuan Huang, Hong Hu, Yuan Li, Fangqiu Fu, Haiquan Chen.
You can read the Full Article in the Journal of Clinical Oncology.
More posts featuring Crispin Hiley.
